EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Reporting a Novel Disease Causing Variant in PGAP3 Associated With Hyperphosphatasia and Intellectual Disability: A Case Report and Comprehensive Literature Review

Arash Salmaninejad iD, Mohammad Reza Seyedtaghia iD, Ali Hosseini Bereshneh iD, Nasrin Azizi iD, Reza Bayat iD, Somaye Esnaashari iD, Vahid Aminzadeh iD, Shahin Koohmanaee iD, Shahram Savad iD, Majid Mojarrad iD, Setila Dalili iD

Molecular Genetics & Genomic Medicine · 2026-03 · 14 (3)

DOI: 10.1002/mgg3.70206 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 22.03.2026. Verfasst von Arash Salmaninejad und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Intellectual Disability, Phosphorus Metabolism Disorders. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A rare autosomal recessive disorder known as hyperphosphatasia with impaired intellectual development syndrome (HPMRS), also referred to as Mabry syndrome, is caused by a deficiency in glycosylphosphatidylinositol (GPI). Elevated blood alkaline phosphatase (ALP) levels, cognitive impairment, and epileptic seizures are among its key features. These pathways are involved in the synthesis of GPI and the transfer of GPI anchor to the proteins, fatty acid remodeling, and transport of GPI‐anchored proteins (GPI‐APs).

Methods

Using exome sequencing (ES), the cause of hyperphosphatasia and ID of an 11‐year‐old girl from non‐consanguineous parents was solved, and the results confirmed by direct Sanger sequencing method.

Results

ES identified a novel homozygous pathogenic variant, PGAP3 (NM_033419.5: c.202dupT, p.Cys68fs*2) that segregated within the family members. To the best of our knowledge at the time of writing this manuscript, this variant has not been reported in HPMRS in the literature.

Conclusion

Our findings indicate that the p.Cys68fs*2 variant may disrupt normal protein function and likely disrupt its interaction with its associated partner proteins, potentially leading to disruption of GPI biosynthesis. We present a novel pathogenic variant thus expanding the phenotypic and mutational spectrum of this extremely rare disorder. Elevated ALP assays and ES are valuable diagnostic tools for HPMRS. Additionally, a comprehensive literature review was conducted to expand the phenotypic and genotypic spectrum within the PGAP3 gene responsible for HPMRS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intellectual DisabilityPhosphorus Metabolism DisordersHumansFemaleChildHomozygoteGlycosylphosphatidylinositolsPhenotypePedigreeAbnormalities, MultipleCarboxylic Ester HydrolasesReceptors, Cell Surface

Stichwörter der Autor:innen

PGAP3Mabry syndromeglycosylphosphatidylinositolhyperphosphatasiaintellectual disability

Substanzen

PGAP3 protein, humanGlycosylphosphatidylinositolsCarboxylic Ester HydrolasesReceptors, Cell Surface

Autor:innen und Institutionen

  • Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Clinical Genomics, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Medical Genetics, Baran Laboratory, Rasht, Iran.
  • Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
  • Children's Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.

ORCID-Profile: Arash Salmaninejad, Mohammad Reza Seyedtaghia, Ali Hosseini Bereshneh, Nasrin Azizi, Reza Bayat, Somaye Esnaashari, Vahid Aminzadeh, Shahin Koohmanaee, Shahram Savad, Majid Mojarrad, Setila Dalili

Zitieren

APA

Salmaninejad, A., Seyedtaghia, M. R., Bereshneh, A. H., Azizi, N., Bayat, R., Esnaashari, S., Aminzadeh, V., Koohmanaee, S., Savad, S., Mojarrad, M., & Dalili, S. (2026). Reporting a Novel Disease Causing Variant in PGAP3 Associated With Hyperphosphatasia and Intellectual Disability: A Case Report and Comprehensive Literature Review. Molecular Genetics & Genomic Medicine, 14(3). https://doi.org/10.1002/mgg3.70206

Vancouver

Salmaninejad A, Seyedtaghia MR, Bereshneh AH, Azizi N, Bayat R, Esnaashari S, et al. Reporting a Novel Disease Causing Variant in PGAP3 Associated With Hyperphosphatasia and Intellectual Disability: A Case Report and Comprehensive Literature Review. Molecular Genetics & Genomic Medicine. 2026;14(3). doi:10.1002/mgg3.70206

BibTeX
@article{Salmaninejad2026,
  author = {Salmaninejad, Arash and Seyedtaghia, Mohammad Reza and Bereshneh, Ali Hosseini and Azizi, Nasrin and Bayat, Reza and Esnaashari, Somaye and Aminzadeh, Vahid and Koohmanaee, Shahin and Savad, Shahram and Mojarrad, Majid and Dalili, Setila},
  title = {Reporting a Novel Disease Causing Variant in PGAP3 Associated With Hyperphosphatasia and Intellectual Disability: A Case Report and Comprehensive Literature Review},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2026},
  volume = {14},
  number = {3},
  doi = {10.1002/mgg3.70206}
}
Kostenlos starten →